Document Detail

Corticotropin-releasing hormone and proopiomelanocortin-derived peptides are present in human myometrium.
MedLine Citation:
PMID:  9768689     Owner:  NLM     Status:  MEDLINE    
CRH and POMC-derived peptides are produced at a number of intrauterine sites in both the nonpregnant and pregnant states. It is hypothesized that CRH and POMC-derived peptides may be produced locally by the uterus to modulate myometrial contractility. This study has examined the distribution of these peptides in human uterine tissue during the ovulatory cycle and pregnancy. The immunoperoxidase staining method was used to localize CRH and POMC-derived peptides: ACTH, beta-endorphin, and alphaMSH. Immunoreactive (IR-) CRH and IR-POMC-derived peptides, beta-endorphin and alphaMSH, were observed in the myometrial smooth muscle, vascular smooth muscle, endometrial glandular epithelium, and luminal epithelium of the nonpregnant uterus (n = 17). Staining for IR-CRH did not change during the cycle from the proliferative (n = 8) to the secretory phases (n = 9). Conversely, staining for IR-beta-endorphin and IR-alphaMSH was only observed during the secretory phase of the cycle (n = 9). In uterine tissue obtained from pregnant women (n = 20) IR-CRH was present in the myometrial smooth muscle, vascular smooth muscle, decidua, and glandular epithelium. IR-POMC-derived peptides were not detectable at any uterine site during pregnancy (n = 20). IR-CRH was measurable in myometrial extracts collected from pregnant women undergoing cesarean section (20.9+/-3.8 ng/g wet wt; n = 7) and from nonpregnant premenopausal women undergoing hysterectomy (7.7+/-2.1 ng/g wet wt; n = 6). IR-CRH concentrations significantly increased with pregnancy. Levels of messenger ribonucleic acid encoding for CRH were examined in nonpregnant (n = 4) and pregnant (n = 10) myometrial smooth muscle and were also significantly increased with pregnancy. This study has demonstrated that levels of CRH and POMC peptide in human uterine tissue change with pregnancy and that CRH is produced locally by myometrial smooth muscle cells. These studies are consistent with the possibility that the CRH peptide has an autocrine/paracrine activity during pregnancy and labor that may be related to the modulation of myometrial contractility.
V L Clifton; J F Telfer; A J Thompson; I T Cameron; T G Teoh; S J Lye; J R Challis
Related Documents :
9800679 - Third-trimester rudimentary horn pregnancy. a case report.
12619849 - Endometrial ablation as an alternative to hysterectomy.
19164479 - Predominance of local over systemic factors in uterine arterial remodeling during pregn...
11384639 - Effects of vaginal progesterone administration on uterine contractility at the time of ...
423019 - Uterine malformation and fetal deformation.
24759939 - Assessment of coupling between trans-abdominally acquired fetal ecg and uterine activit...
3443899 - Clinical aspects of antenatal glucocorticoid treatment for prevention of neonatal respi...
17697069 - Intrauterine growth standards in a developing country: a study of singleton livebirths ...
12901819 - Dual ectopic thyroid: report of a case.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  83     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1998 Oct 
Date Detail:
Created Date:  1998-11-05     Completed Date:  1998-11-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  3716-21     Citation Subset:  AIM; IM    
Department of Physiology, University of Toronto, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Corticotropin-Releasing Hormone / genetics,  metabolism*
Menstrual Cycle / metabolism
Myometrium / metabolism*
Osmolar Concentration
Peptide Fragments / metabolism*
Pro-Opiomelanocortin / metabolism*
RNA, Messenger / metabolism
Tissue Distribution
Reg. No./Substance:
0/Peptide Fragments; 0/RNA, Messenger; 66796-54-1/Pro-Opiomelanocortin; 9015-71-8/Corticotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  17Beta-hydroxysteroid dehydrogenase types 1 and 2 in human placenta: an immunohistochemical study wi...
Next Document:  Cyclic adenosine 3',5'-monophosphate-responsive element modulator gene expression in germ cells of n...